SCHEMBL28537387

SCHEMBL28537387

COc1ccc2cc3n(c2c1C)C(CC(=O)O)CC3

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARD Q03181 3/20 0.37
KDM2B Q8NHM5 4/20 0.36
FFAR1 O14842 2/20 0.36
FFAR4 Q5NUL3 2/20 0.35
GRIN2D O15399 4/20 0.34
GRIN3B O60391 4/20 0.34
GRIN1 Q05586 4/20 0.34
GRIN2A Q12879 4/20 0.34
GRIN2B Q13224 4/20 0.34
GRIN2C Q14957 4/20 0.34
GRIN3A Q8TCU5 4/20 0.34
PPARA Q07869 2/20 0.34
MTNR1A P48039 2/20 0.33
MTNR1B P49286 2/20 0.33
NQO2 P16083 1/20 0.33
PDE4A P27815 1/20 0.33
PDE4B Q07343 1/20 0.33
PDE4C Q08493 1/20 0.33
PDE4D Q08499 1/20 0.33
ALDH1A1 P00352 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2016667 0.88 LMNA (0.38) KDM2BPDE4APDE4BPDE4CPDE4D
SCHEMBL28527343 0.84 GRIN2D (0.38) FFAR1FFAR4GRIN2DGRIN3BGRIN1
SCHEMBL5775631 0.75 GRIN2D (0.39) PPARDFFAR1FFAR4GRIN2DGRIN3B
SCHEMBL5779558 0.73 FFAR1 (0.35) PPARDKDM2BFFAR1FFAR4GRIN2D
SCHEMBL5777080 0.72 FFAR1 (0.35) PPARDFFAR1FFAR4GRIN2DGRIN3B
SCHEMBL2016038 0.70 GRIN2D (0.38) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL2018033 0.69 S1PR1 (0.51)
SCHEMBL5776905 0.69 PTGDR (0.42) FFAR1FFAR4GRIN2DGRIN3BGRIN1
SCHEMBL5778024 0.68 GRIN2D (0.41) FFAR1FFAR4GRIN2DGRIN3BGRIN1
SCHEMBL5776746 0.68 GRIN2D (0.41) FFAR1FFAR4GRIN2DGRIN3BGRIN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105816453-B Substituted tricyclic acid derivatives as S1P1 receptor agonists for the treatment of autoimmune and inflammatory disorders 艾尼纳制药公司 2021-03-05 CN disclosed